Corcept Therapeutics

Associate Director, Clinical Quality Assurance

Corcept Therapeutics  •  $193k - $227k/yr  •  Redwood City, CA (Hybrid)  •  4 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.

Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com

The Associate Director of Clinical Quality Assurance (CQA) is a lead member of the CQA team and will lead and perform day-to-day CQA operations and compliance activities at the clinical program level to support the success of the clinical studies sponsored by Corcept.

This is a hybrid role typically requiring on-site presence at least 3 days per week.

Responsibilities:

  • Lead Clinical Quality Assurance activities and oversee assigned CQA team members to ensure compliance oversight of all clinical studies within a clinical development program
  • Support the management and growth of the CQA team with the goal of attracting and developing talent, creating a rewarding professional environment, and ensuring that the team’s capabilities meet Corcept’s current and future needs
  • Develop/manage study audit plans ensuring compliance oversight for assigned studies by using a risk-based approach
  • Lead/manage Good Clinical Practice (GCP) audits, including clinical investigator site, Trial Master File (TMF), and applicable study documents, including Clinical Study Reports (CSRs)
  • Support clinical service provider and clinical development internal process audits
  • Assess changes to qualified service provider services and their impact to ongoing clinical studies
  • Serve as a CQA Lead representative on assigned clinical studies and provide compliance support and oversight throughout the study lifecycle
  • Evaluate new processes and initiatives impacting clinical programs/studies as CQA representative and support the implementation as needed
  • Support clinical study teams in risk management activities including the identification of critical to quality (CtQ) factors for each clinical study, implementing risk proportionate study activities in accordance with CtQs and the monitoring of identified risks to the CtQs
  • Review clinical study documents and plans and provide CQA compliance review and approval of clinical development SOPs
  • Manage and support GCP inspection readiness activities for assigned clinical program/studies in alignment with study milestones
  • Support regulatory inspections in a key role for assigned programs, including sponsor, clinical investigator site, and service provider inspections
  • Lead critical investigations, to ensure regulatory reporting compliance
  • Support, review and approve clinical non-compliance records (deviations and CAPA)
  • Lead continuous improvement of the Clinical Quality Management System (CQMS), including creation and revision of SOPs and training programs for GCP compliance and excellence
  • Maintain a contemporary knowledge of agency and industry trends, standards, and methodologies related to GCPs
  • Provide cross training development opportunities; mentor and coach junior QA team members
  • Travel required

Preferred Skills, Qualifications and Technical Proficiencies:

  • Ability to prepare for and defend regulatory agency inspections
  • Ability to perform GCP audits is required
  • Experience in developing GCP SOPs and training personnel regarding those SOPs and the government regulations to which they apply
  • Thorough understanding of the quality systems that support internal GCP activities for clinical documentation and clinical trials
  • Excellence in basic Microsoft Office applications (Word, Excel, PowerPoint) is required

Preferred Education and Experience:

  • BA/BS degree in biological sciences, pharmacy, related field or equivalent experience is required
  • 10+ years’ experience development and maintenance of clinical quality systems and performing GCP audits for clinical stage pharmaceutical companies

The pay range that the Company reasonably expects to pay for this headquarters-based position is $192,700 – $226,700; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

Corcept Therapeutics

About Corcept Therapeutics

We’ve been unlocking the potential of cortisol modulation for more than 25 years.

We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Industry
Biotech & Life Sciences
Company Size
501-1,000 employees
Headquarters
Redwood City, California
Year Founded
1998
Social Media